Studying outcomes of sepsis patients in China
Part of Infections clinical trials.
This study looks at the outcomes of people hospitalized with sepsis in China. It helps doctors understand how patients respond to treatment and what factors affect recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and currently hospitalized.
- You have been diagnosed with sepsis according to current medical guidelines.
- You or a legal representative can sign a consent form.
- You have not had sepsis before.
- Your sepsis diagnosis was made within the last 48 hours.
- You are not currently in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.
This trial tests whether Xuebijing injection improves outcomes for adults with sepsis. It looks at how well the treatment works in everyday hospital care, not just in a controlled research setting.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study is tracking people who come to the emergency room with sepsis (a severe response to an infection). It aims to better understand and care for sepsis patients by collecting information about their infections and treatments.
This study follows up with patients who had sepsis in the ICU to understand their long-term health outcomes. It may help improve care for future patients.
This study looks at different types (“endotypes”) of sepsis in adults to better understand what’s happening in the body and how patients may respond. You might be asked to provide information and samples as the study tries to sort sepsis into meaningful subgroups.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.